We are live on ! Find out more
SXTPW icon

60 Degrees Pharmaceuticals Warrant
SXTPW

8 hedge funds and large institutions have $43.9K invested in 60 Degrees Pharmaceuticals Warrant in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 88 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0.5% less ownership

Funds ownership: 6.79%6.29% (-0.5%)

22% less capital invested

Capital invested by funds: $56.3K → $43.9K (-$12.4K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
8
Holders Change
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SM
1
Sabby Management
Florida
$15.5K -$1.41K -24,461 -8%
Walleye Capital
2
Walleye Capital
New York
$12.8K
CS
3
Clear Street
New York
$8.4K -$38 -650 -0.4%
Citadel Advisors
4
Citadel Advisors
Florida
$2.79K +$417 +7,231 +19%
TC
5
Torno Capital
Massachusetts
$2.7K
WAM
6
Warberg Asset Management
Illinois
$1.51K
FDCDDQ
7
Federation des caisses Desjardins du Quebec
Quebec, Canada
$210
UBS Group
8
UBS Group
Switzerland
$3 +$5 +80 New
VF
9
Virtu Financial
New York
-$1K -12,174 Closed

SXTPW Hedge Fund Activity: Q3 2024 in Review

8 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals Warrant (SXTPW) for Q3 2024, worth a combined $43.9K — down 22% from $56.3K a quarter earlier.

Fund positioning in SXTPW was balanced in Q3 2024: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $417. The largest seller was Sabby Management, cutting an estimated $1.41K.

  • 8 institutional investors held 60 Degrees Pharmaceuticals Warrant (SXTPW) as of Q3 2024, unchanged from Q2 2024.
  • Funds reported $43.9K of 60 Degrees Pharmaceuticals Warrant stock for Q3 2024, down 22% quarter-over-quarter.
  • 1 fund opened new 60 Degrees Pharmaceuticals Warrant positions in Q3 2024 and 1 closed out, a net change of 0 holders.
  • The largest 60 Degrees Pharmaceuticals Warrant buyer in Q3 2024 was Citadel Advisors, an estimated $417 added.
  • The largest 60 Degrees Pharmaceuticals Warrant seller in Q3 2024 was Sabby Management, an estimated $1.41K sold.

Based on aggregated 13F filings for Q3 2024.